These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 54510)

  • 21. [Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
    Abele R; Alberto P; Germano G; Obrecht JP; Wagenknecht L
    Schweiz Med Wochenschr; 1976 Jul; 106(28):961-3. PubMed ID: 63145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of mathematical modeling in protocol formulation in cancer chemotherapy.
    Coldman AJ; Goldie JH
    Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCNU, bleomycin, and methylprednisolone with or without adriamycin in renal cel carcinoma: a randomized trial.
    Richards F; Muss HB; White DR; Cooper MR; Spurr CL
    Cancer Treat Rep; 1977 Nov; 61(8):1591-3. PubMed ID: 72604
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer chemotherapy. II.
    Greenwald ES
    N Y State J Med; 1972 Nov; 72(21):2641-54. PubMed ID: 4117677
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy of thyroid malignomas (author's transl)].
    Reinwein D
    Strahlentherapie; 1978 Jun; 154(6):365-7. PubMed ID: 78550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
    Lee SM; Buchler T; Bomanji J; Ramsay A; Edwards SG
    AIDS; 2008 Jan; 22(1):159-60. PubMed ID: 18090408
    [No Abstract]   [Full Text] [Related]  

  • 29. Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
    Tsuruo T; Hamilton TC; Louie KG; Behrens BC; Young RC; Ozols RF
    Jpn J Cancer Res; 1986 Sep; 77(9):941-5. PubMed ID: 2429947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
    Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
    Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 32. [Palliative chemotherapy of bronchial cancers. Current status of the problem].
    Israel L
    Poumon Coeur; 1973; 29(6):691-4. PubMed ID: 4138577
    [No Abstract]   [Full Text] [Related]  

  • 33. [Continuous venous infusion in cancer chemotherapy].
    Ota K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of chemotherapy of inoperable, non-small-cell bronchial carcinomas].
    Fischer M; Mitrou PS
    Internist (Berl); 1980 Feb; 21(2):95-107. PubMed ID: 6154667
    [No Abstract]   [Full Text] [Related]  

  • 35. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen.
    Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E
    Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    Carter SK; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
    [No Abstract]   [Full Text] [Related]  

  • 37. Current perspectives on the use of bleomycin. Introduction.
    Krakoff IH
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):1-2. PubMed ID: 1384137
    [No Abstract]   [Full Text] [Related]  

  • 38. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
    Yagoda A
    Cancer Res; 1977 Aug; 37(8 Pt 2):2775-80. PubMed ID: 68814
    [No Abstract]   [Full Text] [Related]  

  • 39. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 40. Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin.
    Mikhail M; Eichenbaum M; Gerstenfeld E; Duquette J; Pomeranz MK; Polsky D
    J Drugs Dermatol; 2005; 4(1):81-4. PubMed ID: 15696989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.